Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AGN 210676 is a selective agonist of prostaglandin EP2(EC50 : 5 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | AGN 210676 is a selective agonist of prostaglandin EP2(EC50 : 5 nM). |
Targets&IC50 | hEP3A Receptor:153 nM (EC50), hDP Receptor:7749 nM (EC50), EP₂ receptor:5 nM (EC50) |
In vitro | AGN 210676 is useful for the treatment of glaucoma, ocular hypertension, inflammatory bowel disease, and the other diseases or conditions disclosed herein[1]. AGN 210676 (Compound 23) also is a less potent agonist for recombinant human prostaglandin receptors hEP3A and hDP with EC50s of 153 nM and 7749 nM, respectively. |
Synonyms | Simenepag |
Molecular Weight | 431.55 |
Formula | C23H29NO5S |
CAS No. | 910562-15-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AGN 210676 910562-15-1 GPCR/G Protein Immunology/Inflammation Prostaglandin Receptor Simenepag AGN-210676 AGN210676 inhibitor inhibit